
> Rituxan
Rituxan, manufactured by Genentech USA, Inc. and Biogen Idec, Inc., has been linked to serious, life-threatening brain infection called Progressive Multifocal Leukoencephalopathy (PML).
Rituxan is an immunosuppressant used in the treatment of rheumatoid arthritis, B cell non-Hodgkin's lymphoma, B cell leukemia, and some autoimmune disorders. The FDA approved Rituxan in 1997 and in 2006, the labeling was updated to warn patients of the risk of developing PML.
The Schmidt Firm, LLP is currently accepting claims in all 50 states for those who have taken Rituxan and have developed Progressive Multifocal Leukoencephalopathy (PML). If you or somebody you know has taken Rituxan and suffered from PML, you should contact our firm immediately for a free case consultation. Please click here to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Rituxan was approved by the FDA for treatment of treatment of rheumatoid arthritis and non-hodgkins lymphoma. It has recently become a popular treatment of lupus in as an off-label use. In 2006, the FDA released a public health advisory against the development of Progressive Multifocal Leukoencephalopathy or PML infections after the use of Rituxan. Rituxan suppresses the immune system. By suppressing the immune system, patients are at higher risk of developing infections like PML. Two lupus patients who had been using Rituxan developed and died from PML. There have also been 23 other reports from rheumatoid arthritis and lymphoma patients who have been diagnosed with this brain infection.
Progressive Multifocal Leukoencephalopathy (PML) is a serious, rare and fatal viral disease involving inflammation of the white matter of the brain. The following is a list of signs and symptoms related to Progressive Multifocal Leukoencephalopathy:
There are a variety of side effects associated with Rituxan. Our firm is pursing the following types of serious, life-threatening side effects:
The Schmidt Firm, LLP is currently accepting Rituxan induced injury cases in all 50 states. If you or somebody you know has been injured by Rituxan, you should contact our firm immediately for a free case consultation. Please use the form below to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us your case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 920-0753
Secure 128-bit SSL Encrypted Email Communication - Click Here

Brand Name
Rituxan
Generic
Rituximab
Manufacturer
Genentech USA, Inc. and Biogen Idec, Inc.
Status
Public Health Advisory
Related Content
Progressive Multifocal Leukoencephalopathy
Rituxan
Serious Side Effects
Progressive Multifocal Leukoencephalopathy (PML)
Free Rituxan Case Evaluation
Please click here to contact our Dangerous Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
AV® Peer Review Rated Law Firm - An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence. A lawyer must be admitted to the bar for 10 years or more to receive an AV® rating.
Best Lawyers in America
Best Lawyers is the oldest and most respected peer-review publication in the legal profession.
"Top 500 Leading Lawyers in America"
The Lawdragon 500 Leading Lawyers in America is the American consumers guide to locating the best lawyer, in any given field, anywhere in the country.
Super Lawyers
Million Dollar Advocates Forum
Best Lawyers Under 40
American College of Trial Lawyers
International Academy of Trial Lawyers
International Society of Barristers
American Bar Association
American Association for Justice - "Presidents Club"
American Board of Trial Advocates